TY  - GEN
AU  - Barrett,David M
AU  - Teachey,David T
AU  - Grupp,Stephan A
TI  - Toxicity management for patients receiving novel T-cell engaging therapies
SN  - 1531-698X
PY  - 2014///0825
KW  - Antibodies, Bispecific
KW  - adverse effects
KW  - Antigens, CD19
KW  - immunology
KW  - Child
KW  - Cytokines
KW  - biosynthesis
KW  - Humans
KW  - Immune System Diseases
KW  - Immunotherapy
KW  - Lymphocyte Activation
KW  - Lymphohistiocytosis, Hemophagocytic
KW  - Precursor Cell Lymphoblastic Leukemia-Lymphoma
KW  - Receptors, Antigen, T-Cell
KW  - Syndrome
KW  - T-Lymphocytes
N1  - Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review
UR  - https://doi.org/10.1097/MOP.0000000000000043
ER  -